Biomarkers /

GPR32

Back to Biomarkers List

Overview

Location [1]
19q13.33
Protein [2]
Probable G-protein coupled receptor 32
Synonyms [1]
RVDR1

GPR32 is altered in 1.82% of all cancers with breast invasive ductal carcinoma, mixed lobular and ductal breast carcinoma, breast invasive lobular carcinoma, and breast neoplasm having the greatest prevalence of alterations [3].

GPR32 GENIE Cases - Top Diseases

The most common alterations in GPR32 are GPR32 Amplification (1.32%), GPR32 Mutation (0.50%), GPR32 S32F (0.08%), GPR32 A230E (0.04%), and GPR32 D88G (0.04%) [3].

GPR32 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.